Democratic Underground Latest Greatest Lobby Journals Search Options Help Login
Google

Public comments on FDA "guidance document" to close April 30

Printer-friendly format Printer-friendly format
Printer-friendly format Email this thread to a friend
Printer-friendly format Bookmark this thread
This topic is archived.
Home » Discuss » Archives » General Discussion (1/22-2007 thru 12/14/2010) Donate to DU
 
Occulus Donating Member (1000+ posts) Send PM | Profile | Ignore Fri Apr-27-07 12:23 PM
Original message
Public comments on FDA "guidance document" to close April 30
I just found out that the FDA will on April 30th close public comments on a guidance document (.pdf link) which apparently could do some very devastating things to the non-BigPharma health industry, if the guidelines the FDA is taking comments on remains unchanged from its present state.

From the FDA guidance document link (all emphasis is mine):

# "Dietary Supplement"

Section 201(ff) of the Act (21 U.S.C. 321(ff)) defines the term "dietary supplement" as follows:

The term "dietary supplement" -

(1) means a product (other than tobacco) intended to supplement the diet that bears or contains one or more of the following dietary ingredients:

(A) a vitamin;
(B) a mineral;
(C) an herb or other botanical;
(D) an amino acid;
(E) a dietary substance for use by man to supplement the diet by increasing the total dietary intake; or
(F) a concentrate, metabolite, constituent, extract, or combination of any ingredient described in clause (A), (B), (C), (D), or (E);


Vitamins? Minerals? HERBS?? Vitamin C, soon to be available by prescription only?

It gets better:


To illustrate how a CAM product might be a "dietary supplement" under section 201(ff) of the Act, consider botanical products used in naturopathy. (Naturopathy is a CAM whole medical system that views disease as a manifestation of alterations in the processes by which the body heals itself.21 ) For example, naturopathic cranberry tablets might be labeled for use to maintain the health of the urinary tract. In this example, the cranberry tablets generally would be regulated as "dietary supplements" under section 201(ff)(1) of the Act if they were labeled for use to "maintain the health of the urinary tract" rather than "prevent urinary tract infections." The cranberry tablets would be regulated as "drugs" under section 201(g) of the Act if they were labeled for use to "treat urinary tract infections" even if they were labeled as dietary supplements.


It sounds to me that cranberry tablets would be regarded as a "drug", regardless of how they're labeled. I'd like to be wrong about that.

Here's another gem, which appears almost immediately after the one above:

It is possible that certain products used in conjunction with CAM practices may be "cosmetics" under the Act. For example, if a CAM practice involves massage with a moisturizer, the moisturizer could be a "cosmetic" to the extent that it is "rubbed, poured, sprinkled, or sprayed on" the body for beautification or appearance-altering purposes. However, if the moisturizer's intended use is also for the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body, then it may also be subject to regulation as a drug. Other examples of drug/cosmetic combinations are deodorants that are also antiperspirants, moisturizers and makeup marketed with sun-protection claims, and shampoos that also treat dandruff.


The public comments close on the 30th of THIS MONTH. To date, I have not heard a single word from the media on these rule changes. Maybe it was posted here on DU, but if it was, it slipped right by me. Whit exactly is the FDA trying to do, here? I don't think it's too alarmist to talk about "prescription Vitamin C", because they themselves list vitamins in their "guidance document".

If the FDA has a desire to impose rules regulating claims made by the natural/organic/homeopathic health industry, that's one thing, as this industry is one that does need regulation to one extent or another, but these rules appear to go a very great deal further than merely that (such as their own example of cranberry tablets, above). Perhaps this is simply an issue having to do with how these treatments are labeled and/or marketed, but these rules seem to go beyond that.

Does anyone else here know anything more about this? Is there legitimate cause for concern, or are the concerns just a bunch of :tinfoilhat: nonsense?

MAJOR CAVEAT: I did some cursory looking around for articles on this topic. At first, I could find only a link to worldnetdaily- no, I won't link to that site here. However, a couple Google searches returned some interesting results.
Printer Friendly | Permalink |  | Top
kestrel91316 Donating Member (1000+ posts) Send PM | Profile | Ignore Fri Apr-27-07 02:07 PM
Response to Original message
1. This again? Already?
:popcorn:
Printer Friendly | Permalink |  | Top
 
DU AdBot (1000+ posts) Click to send private message to this author Click to view 
this author's profile Click to add 
this author to your buddy list Click to add 
this author to your Ignore list Sun May 05th 2024, 06:55 PM
Response to Original message
Advertisements [?]
 Top

Home » Discuss » Archives » General Discussion (1/22-2007 thru 12/14/2010) Donate to DU

Powered by DCForum+ Version 1.1 Copyright 1997-2002 DCScripts.com
Software has been extensively modified by the DU administrators


Important Notices: By participating on this discussion board, visitors agree to abide by the rules outlined on our Rules page. Messages posted on the Democratic Underground Discussion Forums are the opinions of the individuals who post them, and do not necessarily represent the opinions of Democratic Underground, LLC.

Home  |  Discussion Forums  |  Journals |  Store  |  Donate

About DU  |  Contact Us  |  Privacy Policy

Got a message for Democratic Underground? Click here to send us a message.

© 2001 - 2011 Democratic Underground, LLC